These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7475044)

  • 1. Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats.
    Fleckenstein-Grün G; Thimm F; Frey M; Matyas S
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):207-13. PubMed ID: 7475044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of calcium in arteriosclerosis--experimental evaluation of antiarteriosclerotic potencies of Ca antagonists. Study Group for Calcium Antagonism.
    Fleckenstein-Grün G; Thimm F; Frey M; Czirfusz A
    Basic Res Cardiol; 1994; 89 Suppl 1():145-59. PubMed ID: 7945169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between calcium- and cholesterol-dominated types of arteriosclerotic lesions: antiarteriosclerotic aspects of calcium antagonists.
    Fleckenstein-Grün G; Frey M; Thimm F; Luley C; Czirfusz A; Fleckenstein A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S1-9. PubMed ID: 1725909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
    Chatelain P; Mouton J; Feys G; Laruel A; Manning AS
    Cardiovasc Res; 1995 Dec; 30(6):1038-43. PubMed ID: 8746222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part I. Preventive effects of calcium antagonists in animal experiments.
    Frey M; Just H
    Basic Res Cardiol; 1994; 89 Suppl 1():161-76. PubMed ID: 7945170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities in the future application of calcium antagonists. Is the prevention of blood vessel calcinosis possible?].
    Fleckenstein A; Frey M; Fleckenstein-Grün G
    Fortschr Med; 1984 Jul; 102(27-28):713-7. PubMed ID: 6479813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium--a neglected key factor in arteriosclerosis. The pathogenic role of arterial calcium overload and its prevention by calcium antagonists.
    Fleckenstein-Grün G; Fleckenstein A
    Ann Med; 1991; 23(5):589-99. PubMed ID: 1756029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An electron microscopic study on the structural alteration of the coronary artery of rats induced by vitamin D3].
    Zhang XJ
    Fukuoka Igaku Zasshi; 1991 Mar; 82(3):110-23. PubMed ID: 1648535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem and verapamil prevent vitamin D3-induced myocardial calcium overload in rat papillary muscle: assessment with PVC ETH-123 calcium-selective microelectrodes.
    Gasser R; Byon YK; Frey G; Fleckenstein-Grün G; Fleckenstein A
    Cardiovasc Drugs Ther; 1996 May; 10(2):185-7. PubMed ID: 8842511
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcification of the arterial wall in the aging process. Electron microscopic and biochemical studies of a model of vitamin D3 overdose].
    Seydewitz V; Staubesand J
    Aktuelle Gerontol; 1983 May; 13(3):115-8. PubMed ID: 6135358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vitamin D3-induced vascular calcification by carbocromen.
    Schraven E; Trottnow D; Nitz RE
    Adv Myocardiol; 1983; 4():263-7. PubMed ID: 6304828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of isradipine on lipid parameters in calcinosis in rats induced by vitamin D3].
    Kvaszová E; Turecký L; Viktorínová A
    Bratisl Lek Listy; 1997 Feb; 98(2):91-6. PubMed ID: 9264815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenticular calcium, magnesium, and iron levels in diabetic rats and verapamil effect.
    Cekic O; Bardak Y
    Ophthalmic Res; 1998; 30(2):107-12. PubMed ID: 9523289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotoxicity in swine of a moderate excess of dietary vitamin D3.
    Toda T; Ito M; Toda Y; Smith T; Kummerow F
    Food Chem Toxicol; 1985 Jun; 23(6):585-92. PubMed ID: 2989135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructure of cardiovascular lesions induced by hypervitaminosis D and its withdrawal.
    Taura S; Taura M; Imai H; Kummerow FA; Tokuyasu K; Cho SB
    Paroi Arterielle; 1978 Oct; 4(4):245-59. PubMed ID: 224365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental basis of the long-term therapy of arterial hypertension with calcium antagonists.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1985 Dec; 56(16):3H-14H. PubMed ID: 2416214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of age on vascular calcification induced by vitamin D3 and nicotine].
    Shi Y; Zhou YB; Cai Y; Teng X; Song JQ; Duan XH; Zhang WZ; Qi YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):131-6. PubMed ID: 20396349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D.
    Rajasree S; Umashankar PR; Lal AV; Sarma PS; Kartha CC
    Life Sci; 2002 Mar; 70(15):1777-88. PubMed ID: 12002522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.